Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
uniQure N.V. (QURE)
NASDAQ:QURE
uniQure (QURE) Stock Price & Analysis
791 Followers
QURE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.52 - $28.26
Previous Close$19.3
Volume431.92K
Average Volume (3M)560.63K
Market Cap
$906.76M
Enterprise Value$696.81M
Total Cash (Recent Filing)$352.84M
Total Debt (Recent Filing)$142.89M
Price to Earnings (P/E)-7.1
Beta1.47
Next Earnings
May 01, 2023EPS Estimate
-$0.89Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.72
Shares Outstanding46,815,109
10 Day Avg. Volume505,287
30 Day Avg. Volume560,634
Standard Deviation0.20
R-Squared0.08
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)2.82
Price to Sales (P/S)259.37
Price to Cash Flow (P/CF)2.90
P/FCF Ratio-9.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.54
Enterprise Value/Gross Profit6.76
Enterprise Value/Ebitda-6.45
Forecast
1Y Price Target
$57.88Price Target Upside197.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
uniQure News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QURE FAQ
What was uniQure N.V.’s price range in the past 12 months?
uniQure N.V. lowest stock price was $12.52 and its highest was $28.25 in the past 12 months.
What is uniQure N.V.’s market cap?
Currently, no data Available
When is uniQure N.V.’s upcoming earnings report date?
uniQure N.V.’s upcoming earnings report date is May 01, 2023 which is in 40 days.
How were uniQure N.V.’s earnings last quarter?
uniQure N.V. released its earnings results on Feb 27, 2023. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of -$0.887 by $1.037.
Is uniQure N.V. overvalued?
According to Wall Street analysts uniQure N.V.’s price is currently Undervalued.
Does uniQure N.V. pay dividends?
uniQure N.V. does not currently pay dividends.
What is uniQure N.V.’s EPS estimate?
uniQure N.V.’s EPS estimate is -$0.89.
How many shares outstanding does uniQure N.V. have?
uniQure N.V. has 46,982,487 shares outstanding.
What happened to uniQure N.V.’s price movement after its last earnings report?
uniQure N.V. reported an EPS of $0.15 in its last earnings report, beating expectations of -$0.887. Following the earnings report the stock price went up 5.21%.
Which hedge fund is a major shareholder of uniQure N.V.?
Among the largest hedge funds holding uniQure N.V.’s share is Carlson Capital LP. It holds uniQure N.V.’s shares valued at 907K.
---
uniQure Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$57.88 (197.58% Upside)
$57.88 (197.58% Upside)
Blogger Sentiment
Bullish
QURE Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 20.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.46%
12-Months-Change
Fundamentals
Return on Equity
-23.66%
Trailing 12-Months
Asset Growth
-12.88%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
uniQure N.V.
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.
---
---